Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cell Biochemistry and Biophysics
|
January 23, 2009
Conditional nuclear import and export of yeast proteins using a chemical inducer of dimerization
Srikanth Patury, Prasanthi Geda, Craig J Dobry, et al.
Yeast (Chichester, England)
|
August 1, 2008
A small molecule-directed approach to control protein localization and function
Prasanthi Geda, Srikanth Patury, Jun Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
Journal of the American Chemical Society
|
January 9, 2016
Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody-Drug Conjugates
Jeffrey C Kern, Mark Cancilla, Deborah Dooney, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors
Wensheng Yu, Yongqi Deng, Brett Hopkins, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein Interaction
Michael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Bioconjugate Chemistry
|
June 21, 2018
Development of Anti-CD74 Antibody-Drug Conjugates to Target Glucocorticoids to Immune Cells
Philip E Brandish, Anthony Palmieri, Svetlana Antonenko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cell Biochemistry and Biophysics
|
January 23, 2009
Conditional nuclear import and export of yeast proteins using a chemical inducer of dimerization
Srikanth Patury, Prasanthi Geda, Craig J Dobry, et al.
Yeast (Chichester, England)
|
August 1, 2008
A small molecule-directed approach to control protein localization and function
Prasanthi Geda, Srikanth Patury, Jun Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
Journal of the American Chemical Society
|
January 9, 2016
Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody-Drug Conjugates
Jeffrey C Kern, Mark Cancilla, Deborah Dooney, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors
Wensheng Yu, Yongqi Deng, Brett Hopkins, et al.
Journal of Medicinal Chemistry
|
October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein Interaction
Michael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Bioconjugate Chemistry
|
June 21, 2018
Development of Anti-CD74 Antibody-Drug Conjugates to Target Glucocorticoids to Immune Cells
Philip E Brandish, Anthony Palmieri, Svetlana Antonenko, et al.
Page
of 2